Fatty acid synthase is a metabolic marker of cell proliferation rather than malignancy in ovarian cancer and its precursor cells-Reference-Cited by-同舟云学术

Fatty acid synthase is a metabolic marker of cell proliferation rather than malignancy in ovarian cancer and its precursor cells

Published:2014-11-03 Issue:9 Volume:136 Page:2078-2090
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Veigel Daniel¹²,Wagner Renate¹²,Stübiger Gerald²³,Wuczkowski Michael³,Filipits Martin²⁴,Horvat Reinhard⁵,Benhamú Bellinda⁶,López-Rodríguez María Luz⁶,Leisser Asha¹⁷,Valent Peter²⁷⁸,Grusch Michael²⁴,Hegardt Fausto G.⁹¹⁰¹¹,García Jordi¹⁰¹¹¹²,Serra Dolors⁹¹⁰¹¹,Auersperg Nelly¹³,Colomer Ramón¹⁴¹⁵,Grunt Thomas W.¹²⁷

Affiliation:

1. Signaling Networks Program; Division of Oncology; Department of Medicine I; Medical University Vienna; Vienna Austria

2. Comprehensive Cancer Center, Medical University Vienna; Vienna Austria

3. Department of Vascular Biology and Thrombosis Research; Center of Physiology and Pharmacology, Medical University Vienna; Vienna Austria

4. Institute of Cancer Research; Department of Medicine I; Medical University of Vienna; Vienna Austria

5. Clinical Institute of Pathology; Medical University of Vienna; Vienna Austria

6. Departamento de Química Orgánica I; Facultad de Ciencias Químicas, Universidad Complutense de Madrid; Madrid Spain

7. Ludwig Boltzmann Cluster Oncology; Vienna Austria

8. Division of Hematology and Hemostaseology; Department of Medicine I; Medical University Vienna; Vienna Austria

9. Department of Biochemistry and Molecular Biology; Facultat de Farmàcia, Universitat de Barcelona; Barcelona Spain

10. Institut de Biomedicina de la Universitat de Barcelona (IBUB); Barcelona Spain

11. CIBERobn Fisiopatología de la Obesidad y la Nutrición; Instituto de Salud Carlos III; Madrid Spain

12. Department of Organic Chemistry; Facultat de Química; Universitat de Barcelona; Barcelona Spain

13. Department of Obstetrics and Gynecology; University of British Columbia; Vancouver BC Canada

14. Department of Medical Oncology; Hospital Universitario La Princesa; Madrid Spain

15. Clinical Research Program; Spanish National Cancer Research Center (CNIO); Madrid Spain

Funder

Spanish Ministry of Economy and Competitiveness

CIBER Fisiopatolog de la Obesidad y la NutriciÃ³n (CIBEROBN)

Instituto de Salud Carlos III

National Cancer Institute of Canada

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference42 articles.

1. Major oncogenes and tumor suppressor genes involved in epithelial ovarian cancer (review);Aunoble;Int J Oncol,2000

2. Targeting signaling pathways in ovarian cancer;Reibenwein;Expert Opin Ther Targets,2008

3. Glutamine addiction: a new therapeutic target in cancer;Wise;Trends Biochem Sci,2010

4. Disrupting proton dynamics and energy metabolism for cancer therapy;Parks;Nat Rev Cancer,2013

5. New aspects of the Warburg effect in cancer cell biology;Bensinger;Semin Cell Dev Biol,2012

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fatty acid synthase: A key driver of ovarian cancer metastasis and a promising therapeutic target;Pathology - Research and Practice;2024-08

2. Fatty Acid Synthase (FASN): A Patent Review Since 2016-Present;Recent Patents on Anti-Cancer Drug Discovery;2024-02

3. Regulation of fatty acid synthase on tumor and progress in the development of related therapies;Chinese Medical Journal;2024-01-26

4. Targeting endogenous fatty acid synthesis stimulates the migration of ovarian cancer cells to adipocytes and promotes the transport of fatty acids from adipocytes to cancer cells;International Journal of Oncology;2024-01-11

5. The Cytotoxicity of Cotyledon orbiculata Aqueous Extract and the Biogenic Silver Nanoparticles Derived from the Extract;Current Issues in Molecular Biology;2023-12-14